TGFB1 and neoplasm: Furthermore, its combination with HSP70 vaccine induced a potent anti-tumor immunity by increasing the expression of Th1 cytokines, IL-2, and IFN-γ and decreasing transcription levels of IL-10, TGF-β, and Foxp3 in the tumor microenvironment (262).